← Open Payments lookup

PUSHPARANEE BABUSUKUMAR: Open Payments

NPI 1003919697 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$499 in 25 payments from 11 companies in 2025. Trend: 2023 $58 · 2024 $484 · 2025 $499

Food & beverage: $499
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$79
Neurocrine BioSciences, Inc.3$68
Vanda Pharmaceuticals Inc.3$51
Teva Pharmaceuticals USA, Inc.2$51
ABBVIE INC.3$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$45
Janssen Pharmaceuticals, Inc2$43
Lundbeck LLC2$42
Alkermes, Inc.2$39
Axsome Therapeutics, Inc.1$18

Products named: INGREZZA, FANAPT, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, REXULTI, ABILIFY MAINTENA.

Industry payments across WI — which companies pay providers there.